On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world
Avoid repeated freeze-thaw cycles, label every aliquot with the reconstitution date, and handle throughout under sterile laboratory conditions
Yes, ashwagandha is considered an anti-aging herb because it reduces oxidative stress (cellular damage), lowers cortisol levels, and promotes cellular repair
The only associated side effects with our peptide injections are swelling and redness at the injection sites, but these effects are temporary and short-lived
May offer additional skin protection
Why the absence of data does not mean absence of risk Before you breathe too deep a sigh of relief, consider this